1. Therapeutic Options in Refractory Diabetic Macular Oedema

   • Sanket U. Shah
   • Raj K. Maturi

   Current Opinion 15 February 2017 Pages: 481 - 492

   

2. Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RAs) in the Brain–Adipocyte Axis

   • Bruno Geloneze
   • José Carlos de Lima-Júnior
   • Lício A. Velloso

   Leading Article Open access 23 February 2017 Pages: 493 - 503

   

3. Immunomodulatory Drugs in Multiple Myeloma: Mechanisms of Action and Clinical Experience

   • Sarah A. Holstein
   • Philip L. McCarthy

   Review Article 16 February 2017 Pages: 505 - 520

   

4. JAK–STAT Signaling as a Target for Inflammatory and Autoimmune Diseases: Current and Future Prospects

   • Shubhasree Banerjee
   • Ann Biehl
   • Daniella M. Schwartz

   Review Article 03 March 2017 Pages: 521 - 546

   

5. The Safety of Appropriate Use of Over-the-Counter Proton Pump Inhibitors: An Evidence-Based Review and Delphi Consensus

   • David A. Johnson
   • Philip O. Katz
   • Donald O. Castell

   Review Article Open access 23 February 2017 Pages: 547 - 561

6. Delta-9-Tetrahydrocannabinol/Cannabidiol Oromucosal Spray (Sativex^®): A Review in Multiple Sclerosis-Related Spasticity

   • Gillian M. Keating

   Adis Drug Evaluation 14 March 2017 Pages: 563 - 574

7. Fluocinolone Acetonide Intravitreal Implant 0.19 mg (ILUVIEN^®): A Review in Diabetic Macular Edema

   • Yahiya Y. Syed

   Adis Drug Evaluation 10 March 2017 Pages: 575 - 583

8. Rucaparib: First Global Approval

   • Yahiya Y. Syed

   AdisInsight Report 01 March 2017 Pages: 585 - 592

   

9. Plecanatide: First Global Approval

   • Zaina T. Al-Salama
   • Yahiya Y. Syed

   AdisInsight Report 03 March 2017 Pages: 593 - 598